Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 706 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 


 
RENAL DATA FROM THE ARAB WORLD Table of Contents   
Year : 2008  |  Volume : 19  |  Issue : 1  |  Page : 110-115
Prevalence and Risk Factors for Hepatitis C Virus Infection in Hemodialysis Patients in an Iraqi Renal Transplant Center


Lecturer of Surgery, College of Medicine, Baghdad University, Baghdad, Iraq

Correspondence Address:
Omar Salem Khattab
General and Transplant Surgeon, College of Medicine, Baghdad University, PO Box: 19503, Baghdad
Iraq
Login to access the Email id


PMID: 18087139

Rights and Permissions

Hepatitis C virus (HCV) infection has been recognized as an emerging problem in dialysis patients and its prevalence varies considerably among different areas of the world. The prevalence of HCV infection in hemodialysis (HD) patients and its associated risk factors is not well documented in our country. We therefore performed this study aiming to discuss prevention of further transmission of HCV infection among our patients. Between September 2003 and September 2005, 169 patients with end-stage renal failure on HD at the Renal Transplant Center, Medical City Teaching Hospital, Baghdad, were involved in this prospective study. There were 102 (60.4%) males, and 67 (39.6%) females, with age ranging from 14-67 years. Anti-HCV antibodies were positive in 12 of these patients (7.1%). Female gender, age > 60 years, dialysis duration < six months, history of having received blood transfusion(s), and < 9 hours per week of HD were significant predictors of anti-HCV positivity. We conclude that adherence to universal infection precautions, regular HCV screening of transfusions and of patients on HD and the use of separate machines for those who are anti-HCV positive, are important factors. To further reduce the prevalence in our patients, erythropoietin should replace blood transfusions as also testing for HCV RNA using polymerase chain reaction before starting HD.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2970    
    Printed71    
    Emailed0    
    PDF Downloaded572    
    Comments [Add]    
    Cited by others 10    

Recommend this journal